Scarica l'app Stockscreener
2.03
0.49%
-0.01
Pre-mercato:
2.17
0.14
+6.90%
Precedente Chiudi:
$2.04
Aprire:
$2.05
Volume 24 ore:
50,677
Relative Volume:
2.93
Capitalizzazione di mercato:
$6.46M
Reddito:
$8,700
Utile/perdita netta:
$-8.49M
Rapporto P/E:
-0.4117
EPS:
-4.9303
Flusso di cassa netto:
$-7.39M
1 W Prestazione:
+1.50%
1M Prestazione:
-11.74%
6M Prestazione:
-30.10%
1 anno Prestazione:
-41.35%
Intervallo 1D:
$1.98
$2.05
Intervallo di 1 settimana:
$1.95
$2.075
Portata 52W:
$1.89
$6.47
Heartsciences Inc Stock (HSCS) Company Profile
Nome
Heartsciences Inc
Settore
Industria
Telefono
682-237-7781
Indirizzo
550 RESERVE ST, SUITE 360, SOUTHLAKE
Compare HSCS vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HSCS
Heartsciences Inc
|
2.03 | 6.46M | 8,700 | -8.49M | -7.39M | -4.9303 |
ABT
Abbott Laboratories
|
87.17 | 151.83B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
295.25 | 113.08B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.79 | 99.87B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.98 | 83.21B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.91 | 47.80B | 6.30B | 1.07B | 1.34B | 1.8406 |
Heartsciences Inc Borsa (HSCS) Ultime notizie
HeartSciences signs first SaaS revenues agreement following full launch of MyoVista Insights(TM) - marketscreener.com
HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights™ - The Manila Times
HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights - Weekly Voice
Heartsciences Signs First Saas Revenues Agreement Following Full Launch Of Myovista Insights - TradingView
Colorado hospital becomes first paying MyoVista Insights customer - Stock Titan
HeartSciences (HSCS) Detailed Report | Q1 2026: EPS Tops ViewsDirect Listing - Cổng thông tin điện tử tỉnh Lào Cai
HSCS (HeartSciences Inc.) reports narrower Q1 2026 loss than analyst estimates even as yearly revenue falls sharply, lifting its shares modestly.Debt Refinancing - UBND thành phố Hải Phòng
HSCS (HeartSciences) shares drop 3.2 percent despite Q1 2026 EPS beat as revenue plummets year over year.Dividend Suspension - Cổng thông tin điện tử tỉnh Tây Ninh
HeartSciences (HSCS) Stock Prediction: What’s Next After Recent Move (Breakdown Watch) 2026-04-20 - Newser
HeartSciences (HSCS) Stock: Why Options Traders Watch It (Marginal Gain) 2026-04-15Insider Selling - Cổng thông tin điện tử Tỉnh Sơn La
HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting - 富途牛牛
HeartSciences shareholders have until April 29 to vote online - Stock Titan
Growth Report: Does HeartSciences Inc offer margin of safety2026 Snapshot & Safe Entry Trade Reports - baoquankhu1.vn
Can HeartSciences (HSCS) Stock Reach New Highs | Price at $2.29, Up 0.66%Trending Stock Ideas - Newser
Is HeartSciences (HSCS) Stock Slowing Down | Price at $2.26, Down 1.74%Market Analysis - Newser
HeartSciences Announces Passing of COO Mark Hilz; No Changes to Product Plans or Leadership Structure - Minichart
HeartSciences reports passing of COO Mark Hilz, will not seek immediate replacement - Investing.com Australia
HeartSciences COO and Longtime Board Member Passes Away - TipRanks
HeartSc's COO Mark Hilz dies; served on board since 2013 - TradingView
HeartSciences (HSCS) announces death of COO and director, affirms business plans - Stock Titan
Aug Highlights: Is HeartSciences Inc in a long term uptrend2026 Selloffs & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Exit Recap: Can HeartSciences Inc Equity Warrant outperform under higher oil prices2026 Institutional & Reliable Price Breakout Alerts - baoquankhu1.vn
Aug Retail: Can HeartSciences Inc expand its profit margins2026 Geopolitical Influence & Weekly Setup with High ROI Potential - baoquankhu1.vn
Big Picture: Will HeartSciences Inc Equity Warrant benefit from geopolitical trendsGlobal Markets & Verified Momentum Stock Watchlist - baoquankhu1.vn
HSCSW SEC FilingsHeartSciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan
HeartSciences’ MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System Category - The Manila Times
APPlife Digital Solutions, Inc. Announces Weekly Investor Update Calls to Enhance Transparency and Shareholder Engagement - Weekly Voice
HeartSciences lands Epic Toolbox spot for ECG workflow software - Stock Titan
HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor Meetings - The Manila Times
HeartSciences Inc. to Present at Investor Summit Group Virtual Conference on March 25, 2026 - Quiver Quantitative
HeartSciences CEO to outline strategy in virtual investor meetings - Stock Titan
Pfizer To Rally More Than 34%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga
HSCS Receives Analyst Rating Update: Price Target Lowered by Asc - GuruFocus
Aug Update: What drives HeartSciences Inc Equity Warrants stock price2026 Outlook & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
If You Invested $1,000 in HeartSciences Inc (HSCS) - Stock Titan
Growth Report: Can HeartSciences Inc Equity Warrant ride the EV waveStop Loss & Real-Time Buy Signal Notifications - baoquankhu1.vn
HeartSciences (NASDAQ: HSCS) seeks approval for larger equity plan and officer shield - Stock Titan
Experience real-time quotes, in-depth charts, and analyst ratings - webull.com
HeartSciences Reports Q3 2026 Results, Provides Business Update - National Today
HeartSciences Inc. Reports Fiscal Third Quarter 2026 Financial Results and Progress on MyoVista Insights™ Platform - Quiver Quantitative
HeartSciences (NASDAQ: HSCS) posts fiscal Q3 2026 results and files FDA 510(k) - Stock Titan
HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update - The Globe and Mail
HeartSciences (NASDAQ: HSCS) posts Q3 loss and flags going concern risk - Stock Titan
HeartSciences 10-Q: Revenue $0.00M (Q) / $0.004M (9M); EPS $(0.63) Q, $(2.61) 9M - TradingView
ETF Watch: Can HeartSciences Inc expand its profit marginsDip Buying & Expert Approved Momentum Ideas - baoquankhu1.vn
MACD Signal: Can HeartSciences Inc expand its profit marginsQuarterly Profit Review & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Update Report: Can HeartSciences Inc expand its profit margins2026 Closing Moves & Daily Oversold Bounce Ideas - baoquankhu1.vn
Is HeartSciences Inc. stock undervalued vs historical averages2026 Macro Impact & Safe Swing Trade Setup Alerts - Naître et grandir
Bank Watch: Is SLM Corporation still a buy after recent gainsIndex Update & Fast Entry and Exit Trade Plans - baoquankhu1.vn
Will SmartKem Inc. stock attract more institutional investorsJuly 2025 Intraday Action & Real-Time Volume Trigger Notifications - Naître et grandir
Is HeartSciences Inc. Equity Warrant stock a safe haven assetJuly 2025 Analyst Calls & Intraday High Probability Alerts - Naître et grandir
Heartsciences Inc Azioni (HSCS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.41%
0.93%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):